In gene therapy, promoters act as vital “on/off” switches, dictating whether a therapeutic gene is active and to what extent. While delivery vehicles such as adeno-associated viruses (AAVs) can bring ...

Reshaping the Global Drug Development Landscape with the Industry's Only Natively AI-Powered Omnimodal Foundation Model for Tumor and Immune Biology This recognition directly reflects outcomes that ...

Reshaping the Global Drug Development Landscape with the Industry's Only Natively AI-Powered Omnimodal Foundation Model for Tumor and Immune Biology SAN ANTONIO, Jan. 12, 2026 /PRNewswire/ -- Frost & ...

Last year, a ten-month-old baby in the US was the first person in the world to have their rare genetic disease effectively ...

A new CRISPR-based one-off procedure that lowers "bad" cholesterol has been approved to enter Phase I human trial. If ...

Scientists at the Broad Institute and Mass General Brigham have built a generative AI model that creates short DNA segments ...

A University of California San Diego-led team has discovered that restoring a key cardiac protein called connexin‑43 in a ...

Our genome isn’t as peaceful as it looks—some DNA elements are constantly trying to disrupt it. Scientists studying fruit ...

Alzheimer’s may be driven far more by genetics than previously thought, with one gene playing an outsized role. Researchers ...

Emily A. Buddle has received funding from the Department of Primary Industries and Regions South Australia, the Australian Research Council and Meat and Livestock Australia. She is currently an ...

Using CLASSIC, Rice researchers realized that circuits are variable, having multiple pathways to elicit the same outcome.